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In the kidney, proximal tubules are very important for the reabsorption of water, ions and organic
solutes from the primary urine. They are composed of highly specialized epithelial cells that are
characterized by an elaborate apical brush border to increase transport efﬁciency. Using the pronephric
kidney of Xenopus laevis we discovered that the G-protein modulator cholera toxin resulted in a
dramatic reduction of the proximal tubular size. This phenotype was accompanied by changes in the
cytoarchitecture characterized by ectopic expression of the distal tubular marker 4A6 and an
impairment of yolk platelet degradation. In addition, cholera toxin caused edema formation. However,
this phenotype was not due to kidney defects, but rather due to impaired vasculature development.
Based on experiments with antisense morpholino oligomers as well as pharmacological agonists and
antagonists, we could show that the complex phenotype of cholera toxin in the pronephric kidney was
caused by the hyperactivation of a single G-protein alpha subunit, Gnas. This—in turn—caused elevated
cAMP levels, triggered a Rapgef4-dependent signaling cassette and perturbed exo- and endocytosis.
This perturbation of the secretory pathway by Ctx was not only observed in Xenopus embryos. Also, in a
human proximal tubular cell line, cholera toxin or a Rapgef4-speciﬁc agonist increased uptake and
decreased secretion of FITC-labeled Albumin. Based on these data we propose that the Gnas/cAMP/
Rapgef4 pathway regulates the signals inducing the proliferation of proximal tubules to acquire their
ﬁnal organ size.
& 2013 Elsevier Inc. All rights reserved.Introduction
The kidney is the primary organ for ﬂuid homeostasis (Smith,
1953; Saxe´n, 1987; Vize et al., 2003b). It is required for waste
secretion, but also restricts the loss of water, salts and organic
compounds. The functional unit of the kidney, the nephron, is
subdivided into individual segments along its proximal–distal
axis, each consisting of distinct cell types performing dedicated
functions. Proximal tubules, in particular, play a critical role in
restricting the loss of biologically important molecules by active
re-absorption. To efﬁciently recover most of the solutes, they not
only express high levels of transporters/channels, but also
develop an apical brush border, which increases the cell surface
exposed to the primary urine. Surprisingly, the molecular
mechanisms underlying the functional speciﬁcation of proximal
tubular cells are still poorly understood.ll rights reserved.G-protein coupled receptors (GPCRs) are a very large protein
family characterized by a seven transmembrane domain. This
family consists of over 800 members and regulates many different
cellular aspects (Katritch et al., 2012). GPCRs have important roles
in homeostasis and neurotransmission. It has also become
increasingly clear that they play equally important roles in
development such as the regulation of morphogenetic move-
ments in the embryo (Heisenberg and Solnica-Krezel, 2008). In
contrast to the diversity of ligands and receptors, intracellular
GPCR signaling is relatively simple. In its inactive state a trimeric
G-protein complex (consisting of one alpha subunit associated
with GDP and a beta/gamma dimer) is bound to the GPCR. Upon
receptor activation GDP is replaced by GTP, which causes the
dissociation of the alpha subunit from the beta/gamma dimer and
the activation of downstream signaling. Different downstream
effectors are activated based on the G-protein alpha subunit
subtype. For example, the Gas family increases the cellular cyclic
AMP (cAMP) levels, whereas the Gai family decreases them. The
dissociated beta/gamma subunit initiates its own signaling path-
way mostly by activating phospholipase C (PLC). To inactivate
signaling the GTP bound to the alpha subunit will be hydrolyzed
B. Zhang et al. / Developmental Biology 376 (2013) 31–4232by GTPase activating proteins (GAPs) causing the re-association of
the trimeric complex.
Bacterial toxins have been instrumental in functional analyses
of GPCRs (Aktories, 2011). Pertussis toxin (Ptx), Pasteurella multocida
toxin (Pmt) and Cholera toxin (Ctx) interact and modify a speciﬁc
subset of G-protein alpha subunits and cause their constitutive
activation or inhibition. Ptx ribosylates members of the Gai and Gat
families and thereby prevents dissociation of the trimeric complex
resulting in a constitutive deactivation of these G-proteins. Pmt
deamidates all the members of the Gaq and Gai family as well as
Gna13 of the Ga12/13 family at a speciﬁc glutamine residue. This
prevents their association with GAPs and the hydrolysis of GTP
resulting in hyperactivation. Ctx ribosylates the two members of the
Gas family, Gnas and Gnal, preventing GTP hydrolysis. This causes
elevated cAMP levels, activation of protein kinase A (PKA) and
subsequent phosphorylation of transcription factors such as the
cAMP responsive element binding protein CREB. In addition, cAMP
triggers signaling via Rapgef3/4 (previously known as Epac1/2),
which in turn regulates multiple cellular processes such as exocy-
tosis, cell adhesion and proliferation (Borland et al., 2009).
In this study we utilized the broad range activity of these
toxins to explore the possible functions of G-protein signaling
during kidney development. While the metanephric kidney pre-
sent in most of the higher vertebrates is generally used as a model
to understand these processes, we here used the Xenopus prone-
phros as a paradigm. Compared to the millions of nephrons in the
metanephros, the evolutionarily simpler pronephros has only one
bilateral nephron pair. Nevertheless, nephron function, develop-
ment and cellular speciﬁcation are highly conserved (Zhou and
Vize, 2004; Raciti et al., 2008; Wessely and Tran, 2011). In the
present study, we could show that Ctx has a very speciﬁc and
pronounced effect on proximal tubules. It caused a shortening of
the tubular structures by interfering with cell proliferation. At the
molecular level, this phenotype was caused by hyperactivation of
Gnas signaling via Rapgef4. Moreover, electron microscopy,
uptake/secretion studies using a human proximal tubular cell
line as well as inhibitors of the exo- and endocytotic pathways
suggest that Ctx causes an imbalance of the secretory pathway. As
such these experiments demonstrate—for the ﬁrst time—that
vesicular transport is not only important for the functionality of
fully differentiated proximal tubules, but is also instrumental for
nephron growth.Materials and methods
Embryo manipulations
Xenopus embryos were obtained by in vitro fertilization and
maintained in 0.1x modiﬁed Barth medium (Sive et al., 2000) and
staged according to Nieuwkoop and Faber (1994). Antisense
morpholino oligomers were obtained from GeneTools. The
sequences of the antisense morpholino oligomers used in this
study were 50-AGA CAC CCC ATG GTC CGT GTG GGC T-30 (Gnas-
MO), 50-CCT AAA CAA CCC ATA TTA ATG GTC C-30 (Gnal-MO) and
50-CTT GGC GAA ATC CCA TTA CCT CTG T-30 (Rapgef4-sMO).
Antisense morpholino oligomers were diluted to a concentration
of 1 mM. The pCS2-Gnas-GFP and pCS2-Gnal-GFP constructs were
generated by PCR from pCMV-SPORT6-Gnas and pCMV-SPORT6-
Gnal and subcloned into pCS2-AcGFP. For synthetic mRNA all
plasmids were linearized with NotI and transcribed with SP6
RNA polymerase using the mMessage mMachines (Ambion). For
all the injections a total of 8 nl of morpholino oligomer solution
was injected radially at the 2- to 4-cell stage into Xenopus
embryos. For the GFP reporter assays these injections werefollowed by two injections of 2 ng synthetic mRNA into two
animal blastomeres at the 8-cell stage.
For the drug experiments Xenopus embryos were cultured
until stage 29/30 and treated with the indicated amounts of the
chemical compounds until the untreated controls reached the
desired developmental stage. Drugs were replaced every 24 h.
With the exception of 6-Bnz-cAMP-AM (cAMP-PKA, Biolog Inc), 8-
pCPT-20-O-Me-cAMP-AM (cAMP-Epac, Biolog Inc), Dynasore
(EMD Millipore) and Golgicide A (EMD Millipore) all other
compounds were obtained from Sigma.
Xenopus uptake experiments were performed following the
paradigm developed by Zhou and Vize (2004). Embryos were
exposed to Ctx until stage 35. They were then anesthetized using
500 mg/l MS222 and then injected into the coelomic cavity with
approximately 8 nl of Albumin-FITC (1 mg/ml), 10 kD Dextran-
FITC (50 mg/ml) or 150 kD Dextran–Rhodamine (50 mg/ml). Three
hours later embryos were ﬁxed ﬁrst in 4% PFA (2 h) followed by
Dent’s ﬁxative overnight.
Whole mount in situ hybridization
The procedure for the in situ hybridizations and the analysis by
paraplast sectioning has been previously described (Belo et al.,
1997; Tran et al., 2007). To generate antisense probes plasmids
were linearized and transcribed as follows: pSK-Aplnr—NotI/T7
(Clone ID: 7296250), pSK-b1-Na/K-ATPase—EcoRI/T7 (Tran et al.,
2007), pCMV-SPORT6-Gnal—EcoRI/T7 (Clone ID: 8317937), pCMV-
SPORT6-Gnas—Asp718/T7 (Clone ID: 6864835), pSK-Ncc—EcoRI/T7
(Tran et al., 2007), pSK-Nkcc2—SmaI/T7 (Tran et al., 2007), pCMV-
SPORT6-Nphs1, EcoRI/T7 (Tran et al., 2007), pCMV-SPORT6-Rapgef3—
SalI/T7 (Clone ID: 5571816), pSK-Rapgef4—EcoRI/T7 (Clone ID:
XL099e15), pCMV-SPORT6-Sglt1-K—SalI/T7 (Zhou and Vize, 2004),
pCMV-SPORT6-Slc7a7—SalI/T7 (Raciti et al., 2008), pGEM-T-
Slc7a13—SalI/T7 (Agrawal et al., 2009), pCMV-SPORT6-Slc25a10—
SalI/T7 (Raciti et al., 2008).
Histology, immunohistochemistry and proliferation analysis
For histological staining, Xenopus embryos were ﬁxed in
Bouin’s ﬁxative, cleared in 70% ethanol, embedded in paraplast,
sectioned at 7 mm, dewaxed, and stained with Hematoxylin and
Eosin or Periodic Acid Schiff. For immunohistochemistry embryos
were ﬁxed in Dent’s ﬁxative (4:1 methanol:DMSO). For whole
mount immunostaining, embryos were incubated overnight with
the 3G8 and 4A6 monoclonal antibodies (Vize et al., 1995)
followed by incubation with a Horseradish peroxidase-coupled
anti-mouse secondary antibody and developed using the
ImmPACT DAB kit (Vector Laboratories). The double 3G8/4A6
staining was performed by directly labeling the 4A6 antibody
with Zenons 647 (Invitrogen), while the 3G8 antibody was
visualized with anti-mouse Alexa-555. For the analysis of yolk
platelet proteins embryos were ﬁrst processed for 3G8 antibody
staining on whole mounts (using anti-mouse Alexa-555 as sec-
ondary antibody). Embryos were then embedded in paraplast,
sectioned at 25 mm and probed with anti-vitellogenin or anti-
seryp antibodies (kind gifts of Dr. M. Kirschner) followed by anti-
rabbit Alexa-647. Vitellogenin labeling intensity was quantiﬁed
by the ImageJ software using only the 3G8-positive tubules of 4–5
sections per embryo and ﬁve embryos for each treatment. The
proliferation analysis was performed as described previously
(Romaker et al., 2012).
Transmission electron microscopy
Embryos were ﬁxed in 2.5% glutaradehyde/4% paraformalde-
hyde in 0.2 M cacodylate buffer overnight at 4 1C and postﬁxed in
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buffer they were incubated in 1% uranyl acetate for 1 h, washed
again and dehydrated into propylene oxide. Samples were inﬁl-
trated with Eponate and allowed to polymerize for 24 h. Ultra
thin sections of 85 nm were cut with a diamond knife, stained
with uranyl acetate and lead citrate, and then observed with a
Philips CM12 electron microscope operated at 60 kV.
Uptake and secretion Assays in HK-2 cells
Human proximal tubular cell line, HK-2, was maintained in
Ham’s F-12/DMEM supplemented with 10% FBS, 1% Pen-Strep
(5000 U/ml), 1x ITS (Sigma), 0.7 mg/l Triidothyronine and 60 mg/l
epidermal growth factor. Cells were seeded into 6-well plates,
grown to conﬂuency and starved overnight. For uptake assays the
media was changed to serum-free media containing 50 mg
Albumin-FITC (Sigma) in the presence or absence of the indicated
amounts of Ctx, cAMP-PKA, cAMP-Epac or Brefeldin-A (BFA). After
24 h cells were washed and the amount of retained Albumin-FITC
was measured using a Cytoﬂuor II ﬂuorescence plate reader
(PerSeptive Biosystems). Uptake was calculated as the ratio
between Albumin-FITC divided by the number of living cells
present at the end of the experiment. For secretion assays, cells
were exposed to Albumin-FITC for 24 h and the uptake was
measured (value M1); cells were then changed to serum-free
media without Albumin-FITC, but in the presence or absence of
the indicated amounts of Ctx, cAMP-PKA or cAMP-Epac. After
another 24 h, cells were washed again and the amount of
Albumin-FITC remaining in the cells was measured again (value
M2). Secretion was calculated by M1–M2 divided by the number
of living cells.
Statistical analysis
All experiments were repeated at least three times using
independent fertilizations from different females and the data
were analyzed by Student’s t-test. Dose response curves were
generated by non-linear regression using Prism 4 software.Results
Cholera toxin causes proximal tubule defects
In order to examine the role of GPCRs in Xenopus pronephric
kidney development, we decided to interfere with the activity of
the G-proteins using bacterial toxins (Aktories, 2011). Since we
were interested in the later aspects of pronephros development
(i.e. size control, speciﬁcation and terminal differentiation),
embryos were treated with the drugs at stage 29/30. At this stage
initial speciﬁcation of the kidney anlage has been completed and
the tubules have been patterned along their proximal–distal axis;
analysis was performed at stage 39/40 or later, when the renal
epithelial cells are terminally differentiated and the kidney is
functional (Vize et al., 2003a; Zhou and Vize, 2004; Reggiani et al.,
2007; Raciti et al., 2008; Wessely and Tran, 2011). In the initial
experiment embryos were treated with Pasteurella multocida
toxin (Pmt), Pertussis toxin (Ptx) or Cholera toxin (Ctx) at a dose
of 2 mg/ml and morphology and histology were evaluated. Pmt-
treated embryos were identical to untreated controls and did not
show any overt phenotype (Fig. 1A and B0). Ptx exposure also did
not result in any gross morphological effects, but the cells lining
the tubules appeared disorganized (Fig. 1C, and C0 and data not
shown). It is noteworthy that the dose of Pmt and Ptx used in this
study has been shown to be biologically effective (Durieux et al.,
1992; Orth et al., 2009) and that even higher concentrations didnot cause more pronounced pronephric defects (data not shown).
The most dramatic phenotype was observed with Ctx treatment.
These embryos developed massive edema caused by ﬂuid accu-
mulation within the embryos (Fig. 1D and D0). Using different
concentrations of Ctx, we could establish a dose response curve
for edema formation by Ctx with a median effective dose (ED50) of
23 ng/ml (Fig. 1E).
Fluid accumulation in the embryo is one indication of a non-
functional pronephros, but does not rule out vascular or lympha-
tic defects (Howland, 1916; Kalin et al., 2009). In fact, it has been
previously shown that increasing cAMP levels by Forskolin treat-
ment causes edema by disrupting vascular development (Kalin
et al., 2009). Since the primary outcome of Ctx treatment is
upregulation of cAMP, we therefore examined the vasculature
using apelin receptor (aplnr) expression as a readout (Devic et al.,
1996; Kalin et al., 2009). Whole mount in situ hybridization
demonstrated that Ctx—like Forskolin—dramatically disrupted
vascular gene expression (Fig. 1F and G) suggesting that the
edema phenotype was at least in part caused by a vasculature
defect.
To examine, whether Ctx also caused defects in the pronephros
itself, we used two Xenopus kidney-speciﬁc antibodies, 3G8 and
4A6. These two antibodies label the proximal tubules or the distal
tubules and pronephric duct, respectively ((Vize et al., 1995) and
Fig. 1I and K). Upon Ctx treatment the 3G8-positive proximal
tubules did not show their normal convolutions, but instead were
much smaller and appeared as straight branches only (Fig. 1J). The
growth of proximal tubules is highly regulated during pronephros
development (D.R and O.W. manuscript in preparation). Indeed,
comparing the number of proximal tubular cells between
untreated and Ctx-treated embryos demonstrates that there is
no difference at stage 35, but proximal tubular expansion is
completely blunted at stage 42 in the presence of Ctx (Fig. 1H).
Besides this dramatic change in proximal tubular growth, we
observed another phenotype when the 4A6 staining was exam-
ined. While its pattern in the distal tubules and the pronephric
duct was unchanged, Ctx-treated embryos displayed co-labeling
with 3G8 and 4A6 the in the proximal tubules (Fig. 1L, indicated
by red arrowheads). Like edema formation, ectopic 4A6 staining
was concentration-dependent with a nearly identical ED50 of
31 ng/ml (Fig. 1E). Since 4A6 has never been reported to label
proximal tubules, we co-stained embryos using immunoﬂuores-
cence by distinguishing the two mouse monoclonal antibodies by
Zenons-labeling (Fig. 1M and N). Paraplast sections of the whole
mounts conﬁrmed this observation. Untreated embryos never
displayed any co-staining (Fig. 1O and Q), whereas every single
section of a 3G8-positive tubule was also labeled with 4A6 in Ctx
treated embryos (Fig. 1P and R).
To examine, whether this is due to a change in the patterning
of the pronephros along its proximal–distal axis, we performed
whole mount in situ hybridizations using markers labeling differ-
ent nephron segments (Zhou and Vize, 2004; Raciti et al., 2008)
(Supplementary Fig. S1). The proximal tubular marker Sglt1K, as
well as Slc7A7, Slc25a10 and Slc7a13, markers for the individual
proximal tubular sub-domains, were still expressed in Ctx-treated
embryos. More importantly, genes labeling the other nephron
segments did not show any ectopic staining in the proximal
tubules of Ctx-treated embryos. Based on these data, we conclude
that growth of the proximal tubules, but not pronephric pattern-
ing and speciﬁcation is perturbed by Ctx treatment.
Cholera toxin perturbs the cytoarchitecture of proximal tubular cells
The 4A6 antibody recognizes a yet unidentiﬁed epitope (Vize
et al., 1995). To more thoroughly analyze the phenotype, we
examined the ultrastructure of proximal tubules using transmission
Fig. 1. Cholera toxin causes proximal tubule defects. (A–D0) Xenopus embryos were treated with Pasteurella multocida toxin (Pmt), Pertussis toxin (Ptx) or Cholera toxin
(Ctx) from stage 29/30 until stage 42 and analyzed by morphology (A–D) and H&E staining (A0–D0). Note that only Ctx causes edema formation. (E) Dose response curves
for edema formation (red) and ectopic 4A6 staining (blue) of embryos treated with different doses of Ctx. Each individual data point is the summary of three independent
experiments. The curve was obtained by ﬁtting the data using non-linear regression and used to calculate the median effective doses (ED50). (F and G) Whole mount in situ
hybridization with aplnr comparing untreated and Ctx treated embryos at stage 39. (H) Bar diagram depicting the number of proximal tubular cells at stage 35 and 42 in
untreated and Ctx treated embryos. (I–R) Ctx-treated embryos were analyzed using the 3G8 and 4A6 antibodies at stage 40 in whole mounts (I–N) or paraplast sections
thereof (O–R). Single immunostainings were visualized with DAB, while double stainings were carried out using ﬂuorescent labeled secondary antibodies visualizing 3G8
in red and 4A6 in green. Nuclei were counterstained using DAPI (blue). Ectopic 4A6 staining is indicated by red arrowheads (L).
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B. Zhang et al. / Developmental Biology 376 (2013) 31–42 35electron microscopy (TEM) comparing untreated and Ctx-treated
embryos at stage 42. Tubules of control embryos were well
organized, characterized by cuboidal cell shape, an apical brush
border and tight cell–cell junctions (Fig. 2A and A0). In contrast, Ctx-
treated proximal tubules were less stereotypical when comparing
several specimens. Their cell shape was rather irregular, ranging
from cuboidal to more ﬂattened (Fig. 2B and data not shown); cells
were also often detached from each other and exhibited large gaps
in between (indicated by arrows in Fig. 2B), but they still formed
tight junctions (Fig. 2B0 and data not shown). However, the most
obvious difference in the TEM between untreated and Ctx-treated
samples was the number and size of electron dense black structures,
the yolk platelets. These intracellular, membrane bound organelles
serve as energy source in amphibians and are gradually used up
during embryonic development (Fagotto and Maxﬁeld, 1994;
Jorgensen et al., 2009). Untreated embryos exhibited only a few
remaining yolk platelets in the proximal tubular cells (Fig. 2A). In
contrast, Ctx-treated embryos were markedly enriched in them
(Fig. 2B). This conclusion was conﬁrmed in two ways. First, Periodic
Acid Schiff (PAS) staining detected many more protein-rich granules
in embryos exposed to Ctx (Fig. 2C and D). Secondly, immunoﬂuor-
escence analysis with an antibody against vitellogenin, the main
component of yolk platelets (Jorgensen et al., 2009), demonstrated
more vitellogenin-positive yolk platelets in the proximal tubules of
Ctx-treated embryos (Fig. 2E and F0). Interestingly, this effect was
conﬁned to the proximal tubules, since the distal, 3G8-negative
tubules, did not show any differences (indicated by the asterisks in
Fig. 2E and F).
To explain the effects of Ctx, we envisioned two possible
mechanisms, delayed yolk platelet activation or reduced con-
sumption/degradation. Recently, Jorgensen et al. (2009) showed
that the presence of the yolk protein seryp correlates with the
activation status of yolk platelets. It is present in inactivated yolk
platelets, but is lost when yolk platelets become metabolized. As
reported (Jorgensen et al., 2009), seryp expression was detected in
the pronephric kidney at stage 35 (data not shown), but not at
stage 40 (Fig. 2G). Ctx treatment did not alter this pattern (Fig. 2H
and data not shown). This suggested that constitutive active G-
protein signaling did not delay activation of yolk platelets, but
instead caused reduced vitellogenin consumption/degradation. To
directly test the latter hypothesis, we quantiﬁed the intensity of
the vitellogenin staining in proximal tubules at stage 35 and 40
(Fig. 2I). No effect of Ctx could be detected at the early stage and
vitellogenin expression was high under both conditions. At stage
40, yolk platelets were greatly reduced in untreated control
embryos. However, Ctx-treated embryos did not show any reduc-
tion of staining between the two stages, suggesting that yolk
degradation is really impaired. This hypothesis was also sup-
ported by the transmission electron microscopy. Besides the
electron-dense yolk particles, proximal tubules also exhibit
lighter stained structures that are surrounded by a thick mem-
brane layer (Fig. 2A00), which we believe are intermediates of yolk
platelet degradation. The same structures were also present in the
proximal tubules of Ctx-treated embryos, but were often enclosed
by a thinner membranous layer (Fig. 2B00).
Since we have shown that Ctx inhibited proximal tubular cell
growth (Fig. 1H), we wanted to distinguish, whether the impaired
yolk degradation is a consequence of the absence of proliferation.
To this end, we inhibited cell cycle progression using hydroxyurea
and aphidicolin (HUA, (Harris and Hartenstein, 1991; Tran et al.,
2007)) from stage 29/30 onwards. This caused smaller proximal
tubules (data not shown). More importantly, HUA reduced yolk
degradation as assayed by vitellogenin staining (Fig. 2J and
Supplementary Fig. S2).
Together, these data imply that at the cellular level inhibition
of cell growth by Ctx causes accumulation of yolk platelets.Gnas is the target of cholera toxin
Ctx functions by ribosylating the two members of the Gas
family, Gnas and Gnal, and rendering them constitutively active
(Fig. 3A and (Aktories, 2011)). To identify whether the Xenopus
Ctx phenotype is caused by Gnas, Gnal or a combination of both,
we ﬁrst analyzed the expression of these two G-protein alpha
subunits by whole mount in situ hybridization. As shown in
Fig. 3B Gnas mRNA could be detected in the intermediate
mesoderm (which includes the pronephric tubules and duct as
well as the vasculature), the neural tube and in the brain. On
sections Gnas was particularly strongly expressed in the proximal
tubules with an apical to basolateral gradient (Fig. 3B0 and B00).
Gnal was localized to the olfactory placode and the nephrostomes
of the pronephric kidney (Fig. 3C and C0). Analysis of paraplast
sections suggested that there is also low-level expression in
pronephric tubules and duct (Fig. 3C00).
Since both G-proteins targeted by Ctx were expressed in the
pronephros, either one could be a candidate for the Ctx pheno-
type. Thus, we next eliminated both of them using antisense
morpholino oligomers (MOs) targeting the start codon of either
Gnas (Gnas-MO) or Gnal (Gnal-MO). The efﬁcacy of the two MOs
was veriﬁed using GFP fusion proteins (Supplementary Fig. S3).
Next, each MO was injected at the 2- to 4-cell stage. Embryos
were cultured until stage 29/30 and split into two batches, one of
which was treated with 2 mg/ml Ctx, while the other one was kept
untreated. At stage 40 embryos were processed for immunohis-
tochemistry with 3G8 and 4A6. As shown above Ctx treatment
caused a decrease in proximal tubule size and ectopic 4A6
expression (Fig. 3D, E, K and L). Injection of Gnal-MO did not alter
the Ctx phenotypes (Fig. 3I and P), suggesting that Gnal is not
the target of Ctx in the pronephros. Conversely, injection of
Gnas-MO rendered embryos insensitive to Ctx. Gnas-MO injected
embryos exhibited somewhat smaller proximal tubules, but
exposure to Ctx did not decrease their size even further (Fig. 3G
and J). Similarly, injection of Gnas-MO completely abolished
ectopic 4A6 staining caused by Ctx treatment (Fig. 3N and Q).
Together these data demonstrate that in the absence of Gnas,
Ctx no longer affects the pronephric kidney. This suggests that in
the pronephros Ctx functions solely by hyperactivating Gnas, but
not Gnal.
Activation of Rapgef4 is responsible for the proximal tubular
phenotypes
Canonical downstream signaling of Gnas involves the activa-
tion of adenylate cyclase and the generation of cAMP (Fig. 4A and
(Weinstein et al., 2007)). Indeed, the adenylate cyclase agonist
Forskolin and the phospodiesterase inhibitor IBMX caused iden-
tical phenotypes to Ctx (data not shown and (Kalin et al., 2009)).
To perform a detailed pathway analysis, embryos were next
treated with chemical compounds that either activate or inacti-
vate cAMP signaling (Fig. 4A). Furthermore, to even detect subtle
effects experiments were performed using concentrations close to
the ED50 (30 ng/ml Ctx, 500 ng/ml Forskolin, 150 ng/ml of the
PKA-speciﬁc cAMP analog 6-Bnz-cAMP-AM (cAMP-PKA) and
100 ng/ml of the Rapgef3/4-speciﬁc cAMP analog 8-pCPT-20-O-
Me-cAMP-AM (cAMP-Epac)). As expected, the ED50 of Ctx and
Forskolin induced the entire range of the phenotype in approxi-
mately 50% of the embryos (Fig. 4B F, K, L and S). Surprisingly,
when the PKA inhibitor H89 was used, the Ctx phenotype
separated into two independent branches. H89 rescued edema
formation caused by Ctx or Forskolin, but did not revert the 4A6
and 3G8 staining back to normal (Fig. 4B N and S). The PKA-
speciﬁc cAMP analog 6-Bnz-cAMP-AM conﬁrmed that edema
formation is PKA-dependent (Fig. 4B, O, P and S).
Fig. 2. Interfering with proximal tubular growth caused a defect in yolk platelet degradation. (A to B00) Xenopus embryos were treated with 2 mg/ml Ctx at stage 29/30 and
analyzed at stage 42 using transmission electron microscopy at a 2650-fold (A and B) or 31,000-fold magniﬁcation (A0 , A00 , B0 and B00). Position of the insets is indicated by
the black boxes in (A and B). Arrows indicate the gaps between the proximal tubular cells upon Ctx treatment, arrowheads point towards the membrane layer surrounding
the degrading yolk platelets. (C and D) PAS staining to visualize protein-rich granules in the proximal tubules. Inset shows close-up of a single cell. (E and H)
Immunoﬂuorescence staining of proximal tubules using 3G8 (red), anti-vitellogenin or anti-seryp antibodies (green). (E0 and F0) are close-ups of the proximal tubules
indicated by white boxes in (E and F); the asterisks indicate the distal tubules; nuclei were counterstained with DAPI (blue). (I and J) Quantiﬁcation of anti-vitellogenin
staining for untreated and Ctx treated embryos at stage 35 and 40 (I) as well as untreated and treated with Hydroxyurea/Aphidicolin (HUA) at stage 40 (J).
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Fig. 3. Gnas is the target of cholera toxin action. (A) Schematic of signaling via the Gas G-protein family. The activity of Ctx is indicated in red. (B and C000) In situ
hybridization of Xenopus embryos at stage 35 for Gnas and GnalmRNA by whole mount or paraplast sections thereof. The position of the transverse sections is indicated in
(B and C). (D–Q) Whole mount immunostaining with the 3G8 (D–I) and 4A6 antibody (K–P) in control embryos or embryos injected with the Gnas-MO or the Gnal-MO in
the presence or absence of 2 mg/ml Ctx at stage 40. Ectopic 4A6 staining is indicated by red arrowheads. Quantiﬁcation of proximal tubular cell numbers at stage 42 (J) and
ectopic 4A6 staining at stage 40 (Q) summarizing three independent experiments. Data were analyzed by Student’s t-test with indicating a p value of o0.01.
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become increasingly clear that there are alternative pathways.
Among those Rapgef3/4 (also known as Epac1/2) is the most
prominent one (Holz et al., 2006). To examine this, embryos were
exposed to 8-pCPT-20-O-Me-cAMP-AM, a Rapgef3/4-speciﬁc cAMP
analog. As shown in Fig. 4B and Q–S, this compound showed the
opposite result to the one of the PKA agonist. It caused ectopic 4A6/
reduced 3G8 staining, but not edema formation.
The conclusion that Ctx signals via Rapgef3/4 was based on the
use of a cAMP analog speciﬁc for this pathway. Obviously we
wanted to complement these experiments with a loss-of-function
approach, but a speciﬁc Rapgef3/4 antagonist is unavailable (Holz
et al., 2006). Therefore, we decided to perform loss-of-function
analyses. Since Rapgef3 mRNA was not detectable in the prone-
phros, whereas Rapgef4 was rather ubiquitously expressed with
clearly detectable staining in the proximal tubules of the kidney,
we focused on Rapgef4 (Fig. 4T and T0 and Supplementary Fig. S4).
In the absence of full-length Xenopus laevis Rapgef4 sequence
information we designed an antisense morpholino oligomer
that should prevent correct splicing (Rapgef4-sMO). Unfortu-
nately, the effects of the Rapgef4-sMO were only partial and didnot completely abolish correct splicing (Supplementary Fig. S3).
But since the aim of the experiment was to rescue the effects of
Ctx, we envisioned that even a partial knockdown might sufﬁce.
Therefore, Xenopus embryos were injected at the 2- to 4-cell stage
with Rapgef4-sMO, cultured until stage 29/30 and then split into
two batches, one kept untreated and the other treated with 2 mg/
ml Ctx. At stage 40 embryos were ﬁxed and analyzed by
immunohistochemistry with 3G8 and 4A6. Injection of Rapgef4-
sMO rescued the effect of Ctx treatment (Fig. 4U–BB). Further-
more, and in agreement with the chemical compound analysis
Rapgef4-sMO-injected embryos did not rescue the edema forma-
tion (data not shown).
Based on the data of the pathway analysis, we concluded that
there are two independent phenotypes caused by Ctx treatment
of Xenopus embryos, PKA-dependent edema formation and
Rapgef4-dependent defects in proximal tubular development.
Since edema formation by Ctx is likely due to impaired vasculo-
genesis (Fig. 1G), activation of PKA should also interfere with
vasculogenesis. To test this, we performed whole mount in situ
hybridization with aplnr on embryos treated with the different
agonists/antagonists. As shown in the Supplementary Fig. S5 this
Fig. 4. Activation of Rapgef4 is responsible for the proximal tubular phenotypes. (A) Schematic diagram depicting how Gnas signals to PKA and Rapgef3/4. Pathway
agonists and antagonists are indicated in red or green, respectively. (B–S) Xenopus embryos were treated with multiple compounds modulating Gnas signaling and
analyzed for edema formation at stage 42 (B) and 3G8/4A6 staining (C–S). Red arrowheads indicate ectopic 4A6 staining. Note that all the agonists were used at an ED50
concentration to provide a more sensitive experimental setup. (T and T0) In situ hybridization of Xenopus embryos at stage 35 for Rapgef4 mRNA by whole mount or
paraplast sections thereof. The position of the transverse section is indicated in (T). Close-up in (T) shows the sense control. (U–BB) Whole mount immunostaining with the
3G8 and 4A6 antibody of control embryos or embryos injected with the Rapgef4-sMO in the presence or absence of 2 mg/ml Ctx at stage 40. Ectopic 4A6 staining is indicated
by red arrowheads in (X) and (BB).
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for disruption of aplnr expression, whereas activation of Rapgef4
by 8-pCPT-20-O-Me-cAMP-AM did not cause any changes.
Together, these data indicate that in the developing Xenopus
embryo Ctx regulates vasculogenesis by activating PKA and
proximal tubular growth by activating Rapgef4.
Rapgef3/4 signaling regulates uptake and secretion in proximal
tubular cells
Rapgef4 regulates endo- and exocytosis in a variety of settings
(Shibasaki et al., 2007; Lee et al., 2012). Thus, we wondered,
whether the proximal tubular phenotypes were cause by a defect
in endo- or exocytosis. To this end, we examined protein uptake
in the Xenopus tubules as previously described (Zhou and Vize,
2004). Untreated as well as Ctx treated embryos were injected
with Albumin-FITC into the coelomic cavity. Embryos were ﬁxed
after three hours and processed for 3G8 staining to visualize theproximal tubules. Consistent with the high expression of endo-
cytic receptors in proximal tubules (Christensen et al., 2008),
Albumin was primarily taken up in the proximal tubules both in
untreated as well as Ctx-treated embryos (Fig. 5A and B000).
Identical results were obtained using 10 kD Dextran-FITC and
150 kD Dextran–Rhodamine (Supplementary Fig. S6). However,
when comparing paraplast sections of the whole mounts it
appeared that Ctx resulted in an increased Albumin-FITC uptake
(Fig. 5A000 and B000). Unfortunately, the experimental paradigm was
too variable to exactly quantify the precise level of protein
uptake.
To obtain accurate measurements, we decided to utilize the
human proximal tubular cell line, HK-2. These cells express the
two required apical transport receptors megalin and cubulin and
are well established for uptake studies (Li et al., 2008; Basnayake
et al., 2010). To quantify how Ctx signaling affects protein uptake,
conﬂuent cells were starved for 24 h, exposed to Albumin-FITC in
the absence or presence of Ctx, cAMP-PKA, cAMP-Epac or BFA for
Fig. 5. Cholera toxin regulates albumin uptake and secretion. (A-B000) Untreated or
Ctx-treated Xenopus embryos were injected with Albumin-FITC (green) at stage
35. Embryos were ﬁxed after 3 h, stained with 3G8 (red) and examined in whole
mounts (A and A00 , B and B00) and sections thereof (A000 and B000). DAPI was used to
counterstain nuclei (blue). (C) Schematic for the uptake assay in HK-2 cells. (D) Bar
diagram of Albumin-FITC uptake of HK-2 cells treated with different doses of Ctx,
cAMP-Epac, cAMP-PKA and BFA. (E) Schematic for the secretion assay in HK-2
cells. (F) Bar diagram of Albumin-FITC secretion of HK-2 cells treated with
different doses of Ctx, cAMP-Epac, cAMP-PKA and BFA. Data were analyzed by
Student’s t-test with indicating a p value of o0.05 and a p value of o0.01.
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centrations of Ctx (0.1, 1, 10 mg/ml) increased the uptake of
Albumin-FITC in a dose dependent manner (Fig. 5D and
Supplementary Fig. S6). This effect was Rapgef3/4-dependent as
only cAMP-Epac but not cAMP-PKA could mimic the consequenceof Ctx treatment. Moreover, the Rapgef3/4 antagonist BFA showed
the opposite result and decreased uptake in a concentration-
dependent manner. Since endo- and exocytosis are often linked,
we next tested whether Ctx also affects protein secretion. We
followed a similar paradigm as before, but this time allowed cells
to take up Albumin-FITC in the absence of chemical compounds
and then analyzed its secretion in the presence of drugs (Fig. 5E).
In fact, Rapgef3/4 signaling also regulated dose-dependent secre-
tion of Albumin-FITC (Fig. 5F).
Together these data show that Ctx can effectively modulate
the secretory behavior of proximal tubular cells by increasing
uptake and decreasing secretion.
Imbalance of endo- and exocytosis by Ctx causes
proximal tubular defects
Proliferation is triggered by the secretion of a growth factor, its
binding to a cell surface receptor, the activation of a downstream
signaling pathway and the endocytosis of the receptor to subse-
quently terminate the signal. As such, the growth inhibition
observed in the proximal tubules of the Ctx-treated Xenopus
embryos, may be explained by the defects in endo- and exocytosis
observed in the proximal tubular cell line upon exposure to Ctx.
To test this hypothesis we treated embryos with the endocytosis
inhibitor Dynasore and Golgicide A, a GBF1 inhibitor, which
arrests secretion of soluble and membrane-associated proteins
(Macia et al., 2006; Saenz et al., 2009).
Since Ctx increases endocytosis in HK-2 cells, we tested
whether addition of Dynasore rescued Ctx-treated embryos.
Embryos treated with 50 mM Dynasore alone exhibited smaller
proximal tubules (Fig. 6A, E and K). However, when combined
with Ctx (using its EC50 dose), the cell numbers resembled those
of Dynasore and not those of Ctx (Fig. 6C, E, G and K). This
suggested that proximal tubular growth defect caused by Ctx was
at least in part due to the increased endocytosis. In contrast, the
ectopic 4A6 staining was mostly independent of endocytosis.
Dynasore alone caused some ectopic 4A6 staining, but could
not signiﬁcantly rescue the effects of Ctx treatment (Fig. 6B, D,
F, H and L).
In HK-2 cells Ctx decreased exocytosis. If this was also relevant
in Xenopus embryos, interfering with of exocytosis by Golgicide A
should induce a similar phenotype as Ctx. Indeed, addition of
Golgicide A reduced the size of the proximal tubules and caused
ectopic 4A6 staining (Fig. 6I, J, M and N).
Together these data suggests that in the frog regulation of
endo- and exocytosis by Ctx are also responsible for the proximal
tubular defects.Discussion
Xenopus is a powerful system to study signaling pathways
using low molecular weight compounds that are simply added to
the culture medium (Adams and Levin, 2006). Here we used such
an approach to study the function of G-proteins during later
aspects of pronephros development. Using three toxins, Pmt, Ptx
and Ctx, we grossly perturbed G-protein signaling. Interestingly,
only Pmt did not show any obvious phenotype in kidney forma-
tion or function. Ptx treatment caused cell shape changes in the
pronephric kidney characterized by thicker cell diameters as well
as disruption of the simple cuboidal epithelium (data not shown).
This suggests a defect in cell behavior and one potential signaling
pathway affected by Ptx is non-canonical Wnt signaling. This
pathway involves G-proteins and, indeed, Ptx has been shown to
perturb Wnt activity during tissue separation of the Xenopus
gastrula (Winklbauer et al., 2001; Katanaev et al., 2005; Angers
Fig. 6. Imbalance of endo- and exocytosis by Ctx causes proximal tubular defects. (A–J) Whole mount immunostaining with the 3G8 and 4A6 antibody of control embryos
or embryos treated with 50 mM Dynasore in the presence or absence of 2 mg/ml Ctx or 50 mMGolgicide A at stage 40. (K–N) Bar diagrams quantifying proximal tubular cell
numbers at stage 42 (K and M) and ectopic 4A6 staining at stage 40 (L and N) summarizing three independent experiments. Data were analyzed by Student’s t-test with
indicating a p value of o0.05 and a p value of o0.01. (O) Schematic diagram depicting the proposed mechanism of Ctx in Xenopus embryos (see text for details).
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canonical Wnt signaling pathway are expressed in the developing
Xenopus pronephros (Zhang et al., 2011) and Frizzled-8 has been
implicated in the morphogenetic processes regulating proximal
tubular growth (Satow et al., 2004; Lienkamp et al., 2010).
The toxin causing the most prominent defects was Ctx. It
speciﬁcally interferes with two G-proteins, Gnas and Gnal. While
we did not identify a contribution of Gnal to the Ctx phenotype,
tight regulation of Gnas activity is clearly very important during
late stages of Xenopus embryonic development. Hyperactivation
of Gnas results in severe defects in at least two different organs,
the vasculature and the pronephros. During vascular develop-
ment, it has previously been shown that an increase in cAMP
levels interferes with blood vessel development (Kalin et al.,
2009). This study conﬁrmed those results and extended them
by demonstrating that this phenotype is due to the activation
of PKA.In the pronephros, Ctx caused a reduction of proximal tubules,
ectopic expression of 4A6 and delayed processing of yolk plate-
lets. In particular, the impairment of proximal tubular growth was
very striking. While tubules normally increase in size during
development (Fig. 1H and D.R and O.W. manuscript in prepara-
tion), Ctx completely inhibited this process. We believe that this
phenotype is due to an imbalance of endo- and exocytosis
(Fig. 6O). Ctx activates Rapgef4, which in turn increases endocy-
tosis and decreases exocytosis. Based on the epistasis experi-
ments with Dynasore and Golgicide A we favor the following
scenario: (1) the proximal tubules secrete a growth factor that is
required for cell growth (exocytosis); (2) this (or any other)
growth factor binds to its receptor and activates signaling;
(3) the ligand receptor complex becomes internalized to termi-
nate the signal (endocytosis). Upon treatment with Ctx this
signaling cascade is disrupted at the level of ligand secretion
(which is impaired) and receptor internalization (which is
B. Zhang et al. / Developmental Biology 376 (2013) 31–42 41accelerated). The net effect of these changes can easily explain the
growth defects observed. Obviously, it will be very important to
identify the nature of this signal in the future and test how it is
affected by Ctx.
This hypothesis also explains why Ctx resulted in a dramatic
increase of vitellogenin-positive yolk platelets in the proximal,
but not the distal tubules (Fig. 2). It has recently been proposed
that yolk degradation is initiated by nutritional needs (Jorgensen
et al., 2009). Since Ctx directly interferes with the proliferation of
proximal tubular cells, this obviously reduces the energy need of
those cells. As a consequence yolk degradation is decreased and
yolk platelets are retained.
Finally, a defect in endosomal transportation also explains
another very surprising observation, the fact that proximal
tubular cells stain positive with the 4A6 antibody. In the Xenopus
ﬁeld, the two antibodies 3G8 and 4A6 have been extensively used to
examine pronephros development. Yet, this—to our knowledge—
is the ﬁrst demonstration that proximal tubular cells co-stain for
both antibodies. This was not due to delayed differentiation, since
ectopic 4A6 staining persisted until at least stage 42 (data not
shown); nor was it due to transdifferentiation of proximal tubules,
since the proximal tubules did not acquire the expression of genes
characteristic for intermediate or distal tubules nor did they lose
staining for any proximal tubular marker genes. Unfortunately, the
nature of this co-staining remains unclear, because both antibodies
recognize unknown epitopes. We currently favor the hypothesis that
4A6 recognizes a secreted protein that is present in all cells of the
pronephros. However, proximal tubules have such a high secretion
rate compared to the remainder of the pronephros that 4A6 is
normally undetectable in these cells. Ctx treatment would alter
proximal tubular cells so that their secretory function is less
effective and causes the accumulation of the 4A6 protein. This
explanation is in line with the data that inhibition of endocytosis has
little effect on ectopic 4A6 staining, whereas inhibition of secretion
is sufﬁcient to cause it. Obviously conﬁrmation of this hypothesis
requires the identiﬁcation of the protein recognized by the 4A6
antibody.
One of the main conclusions of the study is that G-protein
activity needs to be tightly controlled during pronephros devel-
opment and too much cAMP is detrimental. Interestingly, the
opposite is not true and too little cAMP has rather subtle
consequences. Inhibiting PKA by H89 did not result in any
pronephric defects. In hindsight, this is not too surprising, since
cAMP/PKA regulates water homeostasis in the metanephric kid-
ney and the main defect of too little cAMP is dehydration.
However, Xenopus embryos live in an aqueous environment and
are hypertonic. Therefore they passively take up water constantly
and lowering cAMP should have little effect. This is underscored
by the observation that the pronephric kidney lacks one of the
main targets of cAMP/PKA in the metanephric kidney, the cystic
ﬁbrosis transmembrane conductance regulator (CFTR) (data not
shown).
In respect to Rapgef4 signaling we indeed did observe a subtle
loss-of-function phenotype. Loss-of-Rapgef4 (as well as Gnas)
caused reduced 4A6 (Fig. 4V and Z and Fig. 3M and N), which is
the opposite of ectopic 4A6 staining caused by gain-of-function.
However, the phenotype was still much more moderate than
using the Rapgef3/4 antagonist Brefeldin-A (data not shown). This
could be due to the fact that the Rapgef4-MO does not completely
inhibit the gene (Supplementary Fig. S3) or is compensated by
Rapgef3. Consistent with this, mouse mutants of Rapgef4 have
much subtler phenotypes than the Rapgef3/4 double mutants
(Shibasaki et al., 2007; Yang et al., 2012).
In conclusion, the present study makes a strong statement for
the importance of G-protein signaling on pronephric kidney
development. This study focused on downstream effectors, butone obvious question is their upstream regulation by GPCRs.
While several GPCRs that cause activation of PKA via Gnas have
been identiﬁed (e.g. Vasopressin receptor or PTH receptor), the
same is not true for Rapgef4. In the future, one will need to
examine individual GPCRs and identify those that actually signal
to Rapgef4. This will not only result in a better understanding of
G-proteins in the pronephric kidney, but also for more general
aspects of kidney function and even human diseases caused by
mutations in Gnas.Acknowledgments
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